glp-1 pharma companies Comparing Ozempic, Wegovy and Other Drugs Compound versions of GLP-1 drugs

If the 2.4 mg maintenance dose is not tolerated, a temporary reduction to 1.7 mg for up to 4 weeks may be considered

Ideal Candidates You're likely a good candidate if you have BMI of 30+ (obesity) or 27+ with weight-related health conditions, have tried diet and exercise without sustained success, are ready to commit to healthier eating, want medically supervised, FDA-approved treatment, and can invest 6-12 months for optimal results

Matthews JE, Stewart MW, De Boever EH, Dobbins RL, Hodge RJ, Walker SE, et al

With both drugs offering unique benefits, a direct comparison helps clarify which option may better support sustainable, effective weight management

doi: 10.1073/pnas.0801059105

These same active ingredients are found in top brand-name weight loss medications, now accessible through our affordable, no-insurance-required program in Rancho Cucamonga, CA